Women with preterm premature rupture of the membranes do not benefit from weekly progesterone

American Journal of Obstetrics and Gynecology

Volumn 204, Issue 1, 2011, Pages 54.e1-54.e5

  Briery, Christian M ^a   Veillon, Edward W ^b   Klauser, Chad K ^c   Martin, Rick W ^b   Magann, Everett F ^d   Chauhan, Suneet P ^e   Morrison, John C ^b  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e Eastern Virginia School of Medicine   (United States)

Author keywords

pregnancy prolongation; preterm premature rupture of membranes; progesterone

Indexed keywords

HYDROXYPROGESTERONE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DRUG EFFECT; DRUG TREATMENT FAILURE; FEMALE; FETUS OUTCOME; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; NEWBORN; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; UTERINE CERVIX DILATATION;

EID: 78650712545     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.08.022     Document Type: Article

References (18)

1. B.M. Mercer Preterm premature rupture of the membranes Obstet Gynecol 101 2003 178 193
2. American College of Obstetricians and Gynecologists ACOG practice bulletin no. 1: clinical management of preterm premature rupture of the membranes Obstet Gynecol 1 1998 848 857
3. J.M. Lieman, C.G. Brumfield, W. Carlo, and P.S. Ramsey Preterm premature rupture of membranes: is there an optimal gestational age for delivery? Obstet Gynecol 105 2005 12 17
4. A.K. Sfakianaki, and E.R. Norwitz Mechanisms of progesterone action in inhibiting prematurity J Matern Fetal Neonatal Med 19 2006 763 772
5. M.R. Peltier, S.C. Tee, and J.C. Smulian Effect of progesterone on proinflammatory cytokine production by monocytes stimulated with pathogens associated with preterm birth Am J Reprod Immunol 60 2008 346 353
6. P.J. Meis, M. Klebanoff, and E. Thom Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate N Engl J Med 348 2003 2379 2385
7. E.B. da Fonseca, R.E. Bittar, M.H. Carvalho, and M. Sugaib Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study Am J Obstet Gynecol 188 2003 419 424
8. E.A. DeFranco, J.M. O'Brien, and C.D. Adair Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial Obstet Gynecol 30 2007 697 705
9. E.W. Veillon, S.D. Keiser, and M.R. Parrish 17-Hydroxyprogesterone blunts the hypertensive response associated with reductions in uterine perfusion pressure in pregnant rats Am J Obstet Gynecol 201 2009 324.e1 324.e6
10. M.A. Elovitz, and C. Mrinalini Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation? Am J Obstet Gynecol 193 2005 1149 1155
11. A. Rebarber, L.A. Ferrara, and M.L. Hanley Increased recurrence of preterm delivery with early cessation of 17-alph-hydroxyprogesterone caproate Am J Obstet Gynecol 196 2007 224.e1 224.e4
12. J.L. Bailit, and M.E. Votruba Medical cost savings associated with 17 alpha-hydroxyprogesterone caproate Am J Obstet Gynecol 196 2007 219.e1 219.e7
13. R. Mackenzie, M. Walker, A. Armson, and M.E. Hannah Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials Am J Obstet Gynecol 194 2006 1234 1242
14. J.M. O'Brien, C.D. Adair, and D.F. Lewis Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial Ultrasound Obstet Gynecol 30 2007 687 696
15. D.J. Rouse, S.N. Caritis, and A.M. Peaceman A trial of 17alpha-hydroxyprogesterone caproate to prevent prematurity in twins N Engl J Med 357 2007 454 461
16. N. Tita, and D.J. Rouse Progesterone for preterm birth prevention: an evolving intervention Am J Obstet Gynecol 200 2009 219 224
17. E.B. Fonseca, E. Celik, M. Parra, S. Mandeep, and K.H. Nicolaides Progesterone and the risk of preterm birth among women with a short cervix N Engl J Med 357 2007 462 469
18. F. Facchinetti, S. Paganelli, G. Comitini, G. Dante, and A. Volpe Cervical length changes during preterm cervical ripening: effects of 17-α-hydroxyprogesterone caproate Am J Obstet Gynecol 196 2007 453.e1 453.e4